| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Epstein barr virusStomach (Neoplasia)Hemophagocytic lymphohistiocytosisLymphoma (T cell)Lymphoproliferative disorders (Viral pathogenesis)Human herpesvirus8Herpesvirus (BASKET)BK VirusCMVMicrobiology (BASKET)AidsHuman herpesvirus7Therapy related lymphoproliferative diseasesStatinLymphoma (Hodgkin)Lymphoma (Burkitt)| 1 | 2006 | Epstein Barr virus hepatitis: case series and review. | 
| + | - | nl | South Med J 99(5):544-7 (2006) |
| 2 | 1987 | Epstein-Barr virus: the spectrum of its manifestations in human beings. | 
| + | - | nl | South Med J 80(8):943-7 (1987) |
| 3 | 2005 | Virological aspects of Epstein-Barr virus infections. | 
| + | - | nl | Acta Med Okayama 59(6):239-46 (2005) |
| 4 | 2004 | A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. | 
| + | - | nl | Acta Med Okayama 58(4):169-80 (2004) |
| 5 | 2006 | MR findings of fulminent leukoencephalopathy in EBV-associated hemophagocytic syndrome. | 
| + | - | nl | Yonsei Med J 47(6):873-6 (2006) |
| 6 | 1989 | The switch between EBV latency and replication. | 
| + | - | nl | Yale J Biol Med 62(2):205-13 (1989) |
| 7 | 2005 | Epstein-Barr virus infections: prospects for treatment. | 
| + | - | nl | J Antimicrob Chemother 56(2):277-81 (2005) |
| 8 | 1995 | Immune regulation in Epstein-Barr virus-associated diseases. | 
| + | - | nl | Microbiol Rev 59(3):387-405 (1995) |
| 9 | 1991 | Severe chronic active Epstein-Barr virus infection syndrome. | 
| + | - | nl | Clin Microbiol Rev 4(1):129-35 (1991) |
| 10 | 1988 | Epstein-Barr virus and human diseases: recent advances in diagnosis. | 
| + | - | nl | Clin Microbiol Rev 1(3):300-12 (1988) |
| 11 | 2009 | Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. | 
| + | - | nl | J Clin Microbiol 47(10):3204-10 (2009) |
| 12 | 2009 | Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. | 
| + | - | nl | Clin Microbiol Infect 15(11):982-8 (2009) |
| 13 | 1994 | The B cell-immortalizing functions of Epstein-Barr virus. | 
| + | - | nl | J Gen Virol 75 ( Pt 1)(-):1-13 (1994) |
| 14 | 2003 | Epstein-Barr virus-associated cancers: aetiology and treatment. | 
| + | - | nl | Herpes 10(3):78-82 (2003) |
| 15 | 1995 | The ecology and pathology of Epstein-Barr virus. | 
| + | - | nl | Immunol Cell Biol 73(6):489-504 (1995) |
| 16 | 2007 | Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. | 
| + | - | nl | Cell Mol Immunol 4(3):185-96 (2007) |
| 17 | 2001 | The immunology of Epstein-Barr virus infection. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 356(1408):475-88 (2001) |
| 18 | 2001 | Biology and disease associations of Epstein-Barr virus. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 356(1408):461-73 (2001) |
| 19 | 2001 | Molecular virology of Epstein-Barr virus. | 
| + | - | nl | Philos Trans R Soc Lond B Biol Sci 356(1408):437-59 (2001) |
| 20 | 2004 | Epstein-Barr virus and cancer. | 
| + | - | nl | Clin Cancer Res 10(3):803-21 (2004) |
| 21 | 2008 | EBV-associated lymphoproliferative disorders: classification and treatment. | 
| + | - | nl | Oncologist 13(5):577-85 (2008) |
| 22 | 2008 | Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. | 
| + | - | nl | Cancer Sci 99(2):195-201 (2008) |
| 23 | 2007 | Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. | 
| + | - | nl | Cancer Sci 98(9):1281-7 (2007) |
| 24 | 1998 | The complexity of the Epstein-Barr virus infection in humans. | 
| + | - | nl | Pathol Oncol Res 4(1):3-7 (1998) |
| 25 | 2005 | Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. | 
| + | - | nl | Am J Hematol 80(1):64-9 (2005) |
| 26 | 1996 | Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis. | 
| + | - | nl | Am J Hematol 53(2):111-5 (1996) |
| 27 | 1994 | Detection and characterization of Epstein-Barr virus in clinical specimens. | 
| + | - | nl | Am J Pathol 145(2):239-52 (1994) |
| 28 | 1993 | NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. | 
| + | - | nl | Ann Intern Med 118(1):45-58 (1993) |
| 29 | 2006 | Epstein-Barr virus: the impact of scientific advances on clinical practice. | 
| + | - | nl | Blood 107(3):862-9 (2006) |
| 30 | 1967 | Infectious mononucleosis. | 
| + | - | nl | Can Med Assoc J 96(17):1212-6 (1967) |
| 31 | 2003 | Epstein-Barr virus latent membrane protein 1: structure and functions. | 
| + | - | nl | J Biomed Sci 10(5):490-504 (2003) |
| 32 | 2011 | Inhibition of germinal centre apoptotic programmes by epstein-barr virus. | 
| + | - | nl | Adv Hematol 2011(-):829525 (2011) |
| 33 | 2009 | Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. | 
| + | - | nl | Ann Oncol 20(9):1472-82 (2009) |
| 34 | 2009 | Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors. | 
| + | - | nl | Cancer Biol Ther 8(11):987-95 (2009) |
| 35 | 2010 | Chromatin organization of gammaherpesvirus latent genomes. | 
| + | - | nl | Biochim Biophys Acta 1799(3-4):236-45 (2010) |
| 36 | 2007 | Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients. | 
| + | - | nl | Clin Infect Dis 45(8):1056-61 (2007) |
| 37 | 2009 | HIV-associated lymphomas and gamma-herpesviruses. | 
| + | - | nl | Blood 113(6):1213-24 (2009) |
| 38 | 2009 | How I treat EBV lymphoproliferation. | 
| + | - | nl | Blood 114(19):4002-8 (2009) |
| 39 | 2010 | Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. | 
| + | - | nl | Clin Microbiol Rev 23(2):350-66 (2010) |
| 40 | 2005 | HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma. | 
| + | - | nl | Br J Cancer 92(9):1593-8 (2005) |
| 41 | 2007 | Epstein Barr virus-associated tumours: an update for the attention of the working pathologist. | 
| + | - | nl | J Clin Pathol 60(12):1358-64 (2007) |
| 42 | 2007 | Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. | 
| + | - | nl | J Clin Pathol 60(12):1342-9 (2007) |
| 43 | 2007 | Epstein-Barr virus and Burkitt lymphoma. | 
| + | - | nl | J Clin Pathol 60(12):1397-402 (2007) |